RARRES2 and chronic pancreatitis: Regarding chemerin’s role in chronic pancreatitis, Adrych et al. [45] first reported increased serum chemerin levels in patients with chronic pancreatitis, independent of diabetes or BMI reduction, suggesting that chemerin reflects local inflammatory and fibrogenic activity rather than adiposity.